Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-20

Clinical Trial Update: Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability [NA]

View source ↗

Summary

A clinical trial is investigating the efficacy of glutamine supplementation for Irritable Bowel Syndrome with impaired intestinal permeability and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutamine (glutamine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Irritable Bowel Syndrome | NA | Status: RECRUITING